Skip to search.
 TSX Down 0.08% TSX Ventures Down 0.36%

Merck & Co. Inc. (MRK)

-NYSE
59.38 Down 0.72(1.20%) May 22, 4:03PM EDT
Add to Portfolio
Prev Close:60.10
Open:60.07
Bid:59.40 x 100
Ask:59.58 x 200
1y Target Est:65.75
Beta:0.47
Next Earnings Date:28-Jul-15MRK Earnings announcement
Day's Range:59.34 - 60.07
52wk Range:52.49 - 63.62
Volume:8,990,387
Avg Vol (3m):11,264,200
Market Cap:167.76B
P/E (ttm):15.43
EPS (ttm):3.85
Div & Yield:1.80 (3.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MRKDown 1.20%167.76B
GSKDown 0.66%109.30B
NVSDown 0.90%251.35B
PFEDown 0.23%211.08B

Key Statistics

Forward P/E (1 yr):15.59
P/S (ttm):4.10
Ex-Dividend Date:12-Mar-15

Analysts

Annual EPS Est (Dec-15) :3.44
Quarterly EPS Est (Jun-15) :0.80
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):3.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback